Research News and Research

RSS

Large tobacco companies fight tougher restrictions around the globe

As sales to developing nations become ever more important to giant tobacco companies, they are stepping up efforts around the world to fight tough restrictions on the marketing of cigarettes.

16 Nov 2010

Leaders speak at Partnership for Maternal, Newborn and Child Health conference

Education for women is the most important factor for positively influencing the health of women and children, Indian President Pratibha Patil said on Saturday at a meeting in New Delhi of The Partnership for Maternal, Newborn & Child Health (PMNCH), IANS/Sify News reports. "Education is a powerful driver of health. The relationship between poverty, lack of education and limited access to health services, is well recognised," Patil said at the start of the two-day conference (11/13).

16 Nov 2010

St. Jude presents results from ASSERT trial for stroke at American Heart Association

St. Jude Medical, Inc., a global medical device company, today announced the results of the ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), a St. Jude Medical sponsored trial conducted by the Population Health Research Institute of McMaster University and Hamilton Health Sciences in Hamilton, Canada.

16 Nov 2010

New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research

A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.

16 Nov 2010

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).

16 Nov 2010

Review: Mercury likely plays role in development of AD

Mercury likely plays a role in the development of Alzheimer's disease, according to a review of relevant scientific literature published this month in The Journal of Alzheimer's Disease. Dr. Joachim Mutter of Germany, Dr. Richard Deth of the United States, and other esteemed researchers collaborated on the groundbreaking article Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism, which clarifies the need for continuing research to understand the cause of neurological diseases such as Alzheimer's.

16 Nov 2010

Sen. Lugar highlights potential bioterrorism threat posed by unsecured medical facilities in East Africa

Senator Dick Lugar on Friday said that poorly secured medical laboratories in East African countries, which host insurgent groups linked to Al Qaeda, are vulnerable to bioterrorism, Agence France-Presse reports.

16 Nov 2010

Research suggests targeting spleen may promote healing of spinal cord injury

The spleen, an organ that helps the body fight infections, might also be a source of the cells that end up doing more harm than good at the site of a spinal cord injury, new research suggests.

16 Nov 2010

Pawlenty seeks to stop health law as he eyes presidency

Kaiser Health News staff writer Christopher Weaver reports, If there was any doubt that protesting on the new health law was good politics for Republican candidates, it evaporated with the midterm election results.

16 Nov 2010

Medicare cuts looming for doctors; Debt panel's health suggestions questioned

"The scheduled cuts [to doctors' reimbursements from Medicare] -- the result of a failed system set up years ago to control costs -- have raised alarms that real damage to Medicare could result if the lame-duck Congress winds up in a partisan standoff and fails to act by Dec. 1. That's when an initial 23 percent reduction would hit. ... Doctors have muddled through with temporary reprieves for years. ... there's no agreement among lawmakers and the Obama administration on how long a reprieve to grant or whether the cost -- about $1 billion per month -- should be added to the deficit or paid for with spending reductions elsewhere" (Alonso-Zaldivar, 11/13).

16 Nov 2010

Scientists reveal that homeopathic consultations can reduce symptoms of rheumatoid arthritis

New evidence that homeopathic consultations can reduce the symptoms of rheumatoid arthritis has been revealed by scientists from the University of Southampton.

16 Nov 2010

Scientists discover new genetic variants linked to bowel cancer

Cancer Research UK-funded scientists have discovered four new genetic variants linked to bowel cancer by combining data from three major genome studies, reveals a study published in Nature Genetics.

16 Nov 2010

Texas Republicans talk tough about dropping Medicaid; other states consider steep cuts

As the Medicaid program continues to consume more of states' budgets each year, Republican lawmakers and the just-reelected GOP governor, Rick Perry have an idea: Opting-out of the program altogether, the Houston Chronicle reports.

16 Nov 2010

FDA approves Halaven therapy for metastatic late-stage breast cancer

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease.

16 Nov 2010

Food, drugs of abuse engage same brain systems, show studies

New animal research helps explain why some eat without hunger or to excess. The studies explore the biological effects of poor eating habits, showing that high-fat diets cause lasting brain changes that may impair healthy eating. Additional studies show that food and drugs of abuse engage many of the same brain systems. The findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

16 Nov 2010

RBC boosting drugs may undermine breast cancer treatment with Herceptin

Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.

16 Nov 2010

Medicare's annual open-enrollment period starts in Idaho

Today marks an important day for roughly 15% of Idaho's population, it's the start of Medicare's annual open-enrollment period, the only time of the year beneficiaries can drop or change prescription drug and health care plans for 2011.

16 Nov 2010

Republicans increase challenges to health law, repeal rhetoric

With their eyes on the 2012 election, Republicans are preparing to maximize conflict with Democrats over healthcare in the new Congress and minimize potential compromises, according to GOP strategists, lawmakers and lobbyists. That strategy is setting the stage for a bitter stalemate on Capitol Hill over the next two years ... Republican leaders and strategists think a renewed battle over healthcare will help the party expand its electoral gains and drive President Obama from the White House.

16 Nov 2010

Elsevier announces availability of eBook collections for advance purchase

Elsevier, the leading publisher of scientific, technical and medical information products and services, announced today its 2011 eBook collections available for advance purchase and to be released on SciVerse ScienceDirect, its online scientific knowledge platform.

16 Nov 2010

Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association

Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).

16 Nov 2010

Research News and Research

Large tobacco companies fight tougher restrictions around the globe

Leaders speak at Partnership for Maternal, Newborn and Child Health conference

St. Jude presents results from ASSERT trial for stroke at American Heart Association

New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Review: Mercury likely plays role in development of AD

Sen. Lugar highlights potential bioterrorism threat posed by unsecured medical facilities in East Africa

Research suggests targeting spleen may promote healing of spinal cord injury

Pawlenty seeks to stop health law as he eyes presidency

Medicare cuts looming for doctors; Debt panel's health suggestions questioned

Scientists reveal that homeopathic consultations can reduce symptoms of rheumatoid arthritis

Scientists discover new genetic variants linked to bowel cancer

Texas Republicans talk tough about dropping Medicaid; other states consider steep cuts

FDA approves Halaven therapy for metastatic late-stage breast cancer

Food, drugs of abuse engage same brain systems, show studies

RBC boosting drugs may undermine breast cancer treatment with Herceptin

Medicare's annual open-enrollment period starts in Idaho

Republicans increase challenges to health law, repeal rhetoric

Elsevier announces availability of eBook collections for advance purchase

Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News